What is LENZ stock price today?

LENZ (Lenz Therapeutics Inc) stock is trading at $10.18 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LENZ stock going up or down today?

LENZ stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LENZ stock now?

The decision to buy LENZ depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LENZ a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LENZ based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LENZ stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LENZ is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LENZ's P/E ratio?

P/E ratio data for LENZ will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LENZ's market cap?

LENZ (Lenz Therapeutics Inc) has a market capitalization of $0.32 billion, making it a small-cap stock.

What is LENZ's price to book ratio?

LENZ trades at a price-to-book (P/B) ratio of 1.12, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LENZ pay dividends?

LENZ does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LENZ's dividend yield?

LENZ does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LENZ stock a good long-term investment?

LENZ's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LENZ's revenue growth rate?

Revenue growth data for LENZ is available on our dashboard with detailed financial statement analysis.

Profitability metrics for LENZ are available on our dashboard with complete income statement analysis.

What are the risks of investing in LENZ?

Key risks for LENZ include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LENZ compare to its competitors?

Compare LENZ to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LENZ's performance and positioning.

What is LENZ's stock price target for 2026?

Our AI model provides price targets for LENZ based on fundamental analysis: Bull case $13.23 (+30%), Base case $11.71 (+15%), Bear case $9.16 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LENZ?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LENZ. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LENZ's next earnings report?

LENZ reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LENZ - Lenz Therapeutics Inc

NYSE * Health Care * Biotechnology

$10.18

+$0.54 (+5.60%)

About Lenz Therapeutics Inc

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

LENZ Key Statistics

Market Cap

$319.19M

P/B Ratio

1.12

EPS

$-2.85

Employees

152

How LENZ Compares to Peers

LENZ is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LENZ(This stock)	$319.19M	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Lenz Therapeutics Inc Company Information

Headquarters: California; U.S.A
Website: www.lenz-tx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 19, 2026 at 12:51 AM EDT

Ready to invest in LENZ?

Commission-free trading available. Affiliate links.

LENZ Lician Score

5% confidence

4.0/10

Neutral

LENZ has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates LENZacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

LENZ Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for LENZ

Dashboard

Enter a ticker to analyze